AR Asset Management’s Gilead Sciences GILD Stock Holding History

AR Asset Management’s Portfolio GILD Stock Details GILD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q3	–	Sell	-7,000	Closed	-$496K	–	115
2018 Q2	$496K	Hold	7,000	–	–	0.19%	93
2018 Q1	$528K	Hold	7,000	–	–	0.21%	85
2017 Q4	$501K	Hold	7,000	–	–	0.19%	90
2017 Q3	$567K	Hold	7,000	–	–	0.22%	84
2017 Q2	$495K	Hold	7,000	–	–	0.2%	91
2017 Q1	$475K	Hold	7,000	–	–	0.2%	87
2016 Q4	$501K	Sell	7,000 -3,800	-35%	-$282K	0.21%	86
2016 Q3	$854K	Hold	10,800	–	–	0.37%	66
2016 Q2	$901K	Hold	10,800	–	–	0.38%	62
2016 Q1	$992K	Buy	10,800 +1,800	+20%	+$162K	0.43%	57
2015 Q4	$911K	Hold	9,000	–	–	0.41%	63
2015 Q3	$884K	Buy	+9,000	New	+$1,000K	0.39%	66

Other funds holding GILD

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

AR Asset Management's GILD Position: Q3 2018 in Review

AR Asset Management sold out of Gilead Sciences (GILD) in Q3 2018, closing a stake of 7,000 shares — an estimated $496K sold.

AR Asset Management first reported a position in GILD in Q3 2015 and held it in 12 quarters. The position peaked at $992K in Q1 2016. 1,528 funds tracked by Wall St. Rank hold GILD as of Q3 2018.

AR Asset Management reported no remaining Gilead Sciences position as of Q3 2018 after selling out during the quarter.
AR Asset Management sold 7,000 Gilead Sciences shares in Q3 2018, an estimated $496K.
AR Asset Management first reported a position in Gilead Sciences in Q3 2015 and held it in 12 quarters.
AR Asset Management's Gilead Sciences position peaked at $992K in Q1 2016.
1,528 funds tracked by Wall St. Rank held Gilead Sciences as of Q3 2018.

Based on AR Asset Management's 13F filing for Q3 2018, filed 9 Nov 2018.